Novonesis (Novozymes A/S) (NVZMF)
55.94
-3.32
(-5.60%)
USD |
OTCM |
May 18, 16:00
Novonesis (Novozymes A/S) EPS Diluted (Quarterly) : 0.4996 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arq, Inc. | -0.0202 |
| Albemarle Corp. | 2.339 |
| Air Products & Chemicals, Inc. | 3.187 |
| Ashland, Inc. | 0.3478 |
| American Vanguard Corp. | -0.1447 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 232.93M |
| Revenue (Quarterly) | 1.309B |
| Total Expenses (Quarterly) | 1.077B |
| Enterprise Value | 29.40B |
| Gross Profit Margin (Quarterly) | 56.66% |
| Profit Margin (Quarterly) | 17.79% |
| Earnings Yield | 2.65% |
| Operating Earnings Yield | 3.81% |
| Normalized Earnings Yield | 2.837 |